tiprankstipranks
Shield Therapeutics PLC (DE:1JS)
FRANKFURT:1JS
Germany Market
1JS
Shield Therapeutics
RESEARCH TOOLSreports

Shield Therapeutics (1JS) Ratios

2 Followers

Shield Therapeutics Ratios

DE:1JS's free cash flow for Q2 2026 was £0.58. For the 2026 fiscal year, DE:1JS's free cash flow was decreased by £ and operating cash flow was £<0.01. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.75 0.90 1.16 2.90 0.95
Quick Ratio
 0.55 0.72 0.99 2.60 0.81
Cash Ratio
 0.18 0.23 0.22 1.29 0.27
Solvency Ratio
 -0.13 -0.21 -0.43 -1.22 -2.26
Operating Cash Flow Ratio
 -0.27 -0.18 -0.27 -3.45 -1.72
Short-Term Operating Cash Flow Coverage
 0.00 0.00 -56.01 -221.16 -205.14
Net Current Asset Value
£ -36.49M$ -35.09M$ -20.84M$ 4.78M£ -6.55M
Leverage Ratios
Debt-to-Assets Ratio
 0.46 0.46 0.46 0.42 0.28
Debt-to-Equity Ratio
 -1.46 -2.00 -20.02 1.73 1.12
Debt-to-Capital Ratio
 3.16 2.00 1.05 0.63 0.53
Long-Term Debt-to-Capital Ratio
 3.16 2.00 1.05 0.63 0.53
Financial Leverage Ratio
 -3.15 -4.33 -43.64 4.14 4.07
Debt Service Coverage Ratio
 -0.65 -1.28 -5.31 -31.60 -110.06
Interest Coverage Ratio
 -0.69 -1.36 -5.92 -38.22 -79.09
Debt to Market Cap
 0.34 0.35 1.08 0.41 0.37
Interest Debt Per Share
 0.03 0.04 0.03 0.03 0.03
Net Debt to EBITDA
 -5.08 -2.02 -0.93 -0.21 -0.07
Profitability Margins
Gross Profit Margin
50.58%44.11%41.97%30.78%36.32%
EBIT Margin
-7.02%-20.29%-70.25%-239.66%-889.98%
EBITDA Margin
-5.60%-18.05%-65.82%-231.47%-837.73%
Operating Profit Margin
-7.02%-20.29%-72.59%-239.44%-479.92%
Pretax Profit Margin
-16.81%-34.49%-82.52%-247.42%-728.90%
Net Profit Margin
-17.76%-35.52%-84.47%-254.44%-735.48%
Continuous Operations Profit Margin
-17.76%-35.52%-84.47%-254.44%-735.05%
Net Income Per EBT
105.64%103.00%102.36%102.84%100.90%
EBT Per EBIT
239.48%169.95%113.68%103.33%151.88%
Return on Assets (ROA)
-19.27%-27.63%-46.35%-68.22%-183.22%
Return on Equity (ROE)
64.57%119.51%2022.89%-282.32%-745.24%
Return on Capital Employed (ROCE)
-51.87%-68.36%-92.11%-82.40%-230.79%
Return on Invested Capital (ROIC)
-51.87%-68.36%-90.82%-81.58%-226.90%
Return on Tangible Assets
-29.15%-38.89%-67.77%-104.25%-393.00%
Earnings Yield
-13.94%-20.76%-108.89%-68.77%-246.01%
Efficiency Ratios
Receivables Turnover
 3.44 2.08 1.25 1.23 1.47
Payables Turnover
 2.73 0.76 0.79 2.24 1.42
Inventory Turnover
 3.16 3.08 3.23 2.83 1.70
Fixed Asset Turnover
 524.42 448.90 84.56 19.44 27.91
Asset Turnover
 1.09 0.78 0.55 0.27 0.25
Working Capital Turnover Ratio
 -7.13 276.68 1.85 1.31 0.82
Cash Conversion Cycle
 87.97 -187.81 -57.26 261.59 208.06
Days of Sales Outstanding
 106.04 175.43 292.25 295.68 249.14
Days of Inventory Outstanding
 115.57 118.63 112.89 129.07 215.31
Days of Payables Outstanding
 133.64 481.87 462.40 163.16 256.39
Operating Cycle
 221.61 294.06 405.14 424.75 464.44
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.01 >-0.01 >-0.01 -0.05 -0.08
Free Cash Flow Per Share
 -0.01 -0.01 >-0.01 -0.06 -0.09
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.08 1.10
Dividend Paid and CapEx Coverage Ratio
 -236.20 -359.45 -255.78 -12.59 -9.63
Capital Expenditure Coverage Ratio
 -236.20 -359.45 -255.78 -12.59 -9.63
Operating Cash Flow Coverage Ratio
 -0.49 -0.29 -0.33 -1.82 -2.99
Operating Cash Flow to Sales Ratio
 -0.21 -0.17 -0.28 -2.84 -3.32
Free Cash Flow Yield
-16.50%-10.17%-36.01%-82.78%-122.52%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -7.12 -4.80 -0.92 -1.45 -0.41
Price-to-Sales (P/S) Ratio
 1.28 1.71 0.78 3.70 2.99
Price-to-Book (P/B) Ratio
 -4.36 -5.76 -18.58 4.11 3.03
Price-to-Free Cash Flow (P/FCF) Ratio
 -6.06 -9.83 -2.78 -1.21 -0.82
Price-to-Operating Cash Flow Ratio
 -6.08 -9.86 -2.79 -1.30 -0.90
Price-to-Earnings Growth (PEG) Ratio
 -0.07 0.16 0.02 0.02 >-0.01
Price-to-Fair Value
 -4.36 -5.76 -18.58 4.11 3.03
Enterprise Value Multiple
 -27.83 -11.50 -2.11 -1.81 -0.43
Enterprise Value
 91.25M 105.33M 43.77M 54.88M 19.72M
EV to EBITDA
 -27.83 -11.50 -2.11 -1.81 -0.43
EV to Sales
 1.56 2.08 1.39 4.19 3.59
EV to Free Cash Flow
 -7.41 -11.93 -4.97 -1.37 -0.98
EV to Operating Cash Flow
 -7.44 -11.96 -4.99 -1.48 -1.08
Tangible Book Value Per Share
 -0.03 -0.04 -0.02 <0.01 -0.03
Shareholders’ Equity Per Share
 -0.02 -0.02 >-0.01 0.02 0.02
Tax and Other Ratios
Effective Tax Rate
 -0.06 -0.03 -0.02 -0.03 -0.01
Revenue Per Share
 0.05 0.06 0.03 0.02 0.02
Net Income Per Share
 >-0.01 -0.02 -0.03 -0.05 -0.17
Tax Burden
 1.06 1.03 1.02 1.03 1.01
Interest Burden
 2.39 1.70 1.17 1.03 0.82
Research & Development to Revenue
 0.03 0.03 0.06 0.14 0.19
SG&A to Revenue
 0.55 0.61 1.07 1.16 4.97
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.07 0.17
Income Quality
 1.20 0.49 0.33 1.12 0.64